I agree that this site is using cookies. You can find further informations here.
X
Ulazia-Garmendia, Ane
21  results:
Search for persons X
?
1

A DNA Methylation-Based Gene Signature Can Predict Triple-N..:

Mendaza, Saioa ; Guerrero-Setas, David ; Monreal-Santesteban, Iñaki...
Biomedicines.  9 (2021)  10 - p. 1394 , 2021
Link: https://doi.org/10.3390/..
 
?
2

ADAM12 is A Potential Therapeutic Target Regulated by Hypom..:

Mendaza, Saioa ; Ulazia-Garmendia, Ane ; Monreal-Santesteban, Iñaki...
International Journal of Molecular Sciences.  21 (2020)  3 - p. 903 , 2020
Link: https://doi.org/10.3390/..
 
?
3

CHL1 hypermethylation as a potential biomarker of poor prog..:

Martín-Sánchez, Esperanza ; Mendaza, Saioa ; Ulazia-Garmendia, Ane...
Oncotarget.  8 (2017)  9 - p. 15789-15801 , 2017
Link: https://doi.org/10.18632..
 
?
4

CDH22 hypermethylation is an independent prognostic biomark..:

Martín-Sánchez, Esperanza ; Mendaza, Saioa ; Ulazia-Garmendia, Ane...
Clinical Epigenetics.  9 (2017)  1 - p. , 2017
Link: https://doi.org/10.1186/..
 
?
5

ADAM12 is A Potential Therapeutic Target Regulated by Hypom..:

Mendaza, Saioa ; Ulazia-Garmendia, Ane ; Monreal-Santesteban, Iñaki...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036924/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
6

CDH22 hypermethylation is an independent prognostic biomark..:

Martín-Sánchez, Esperanza ; Mendaza, Saioa ; Ulazia-Garmendia, Ane...
http://www.clinicalepigeneticsjournal.com/content/9/1/7.  , 2017
Link: http://www.clinicalepige..
 
?
7

CHL1 hypermethylation as a potential biomarker of poor prog..:

Martín-Sánchez, Esperanza ; Mendaza, Saioa ; Ulazia-Garmendia, Ane...
Reproducció del document publicat a: https://doi.org/10.18632/oncotarget.15004.  , 2017
Link: http://hdl.handle.net/24..
 
?
8

CHL1 hypermethylation as a potential biomarker of poor prog..:

Martín-Sánchez, Esperanza ; Mendaza, Saioa ; Ulazia-Garmendia, Ane...
https://doi.org/10.18632/oncotarget.15004..  , 2017
Link: https://hdl.handle.net/2..
 
?
9

A DNA Methylation-Based Gene Signature Can Predict Triple-N..:

Saioa Mendaza ; David Guerrero-Setas ; Iñaki Monreal-Santesteban...
https://dx.doi.org/10.3390/biomedicines9101394.  , 2021
Link: https://doi.org/10.3390/..
 
?
10

A DNA Methylation-Based Gene Signature Can Predict Triple-N..:

Saioa Mendaza ; David Guerrero-Setas ; Iñaki Monreal-Santesteban...
https://www.mdpi.com/2227-9059/9/10/1394.  , 2021
Link: https://doi.org/10.3390/..
 
?
11

ADAM12 is A Potential Therapeutic Target Regulated by Hypom..:

Saioa Mendaza ; Ane Ulazia-Garmendia ; Iñaki Monreal-Santesteban...
https://www.mdpi.com/1422-0067/21/3/903.  , 2020
Link: https://doi.org/10.3390/..
 
?
12

ADAM12 is A Potential Therapeutic Target Regulated by Hypom..:

Saioa Mendaza ; Ane Ulazia-Garmendia ; Iñaki Monreal-Santesteban...
Molecular Oncology.  , 2020
Link: https://doi.org/10.3390/..
 
?
13

A DNA methylation-based gene signature can predict triple-n..:

Mendaza Lainez, Saioa ; Guerrero Setas, David ; Monreal Santesteban, Iñaki...
Biomedicines, 9 (10).  ,
Link: https://hdl.handle.net/2..
 
?
14

Búsqueda de nuevos biomarcadores epigenéticos en cáncer de ..:

Ulazia Garmendia, Ane
https://hdl.handle.net/2454/23037.  ,
Link: https://hdl.handle.net/2..
 
?
15

ADAM12 is a potential therapeutic target regulated by hypom..:

Mendaza Lainez, Saioa ; Ulazia Garmendia, Ane ; Monreal Santesteban, Iñaki..
International Journal of Molecular Sciences, 2020, 21 (3), 903.  ,
Link: https://hdl.handle.net/2..
 
1-15